Pd Rx Pharmaceutical Stock Performance
| PDRX Stock | USD 3.33 0.00 0.00% |
On a scale of 0 to 100, Pd Rx holds a performance score of 9. The company owns a Beta (Systematic Risk) of -0.12, which implies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Pd Rx are expected to decrease at a much lower rate. During the bear market, Pd Rx is likely to outperform the market. Please check Pd Rx's risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and rate of daily change , to make a quick decision on whether Pd Rx's current price history will revert.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Pd Rx Pharmaceutical are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile basic indicators, Pd Rx showed solid returns over the last few months and may actually be approaching a breakup point. ...more
PDRX |
Pd Rx Relative Risk vs. Return Landscape
If you would invest 290.00 in Pd Rx Pharmaceutical on October 25, 2025 and sell it today you would earn a total of 43.00 from holding Pd Rx Pharmaceutical or generate 14.83% return on investment over 90 days. Pd Rx Pharmaceutical is currently generating 0.2406% in daily expected returns and assumes 1.9604% risk (volatility on return distribution) over the 90 days horizon. In different words, 17% of pink sheets are less volatile than PDRX, and 96% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Pd Rx Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pd Rx's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Pd Rx Pharmaceutical, and traders can use it to determine the average amount a Pd Rx's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Based on monthly moving average Pd Rx is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Pd Rx by adding it to a well-diversified portfolio.
Pd Rx Fundamentals Growth
PDRX Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Pd Rx, and Pd Rx fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on PDRX Pink Sheet performance.
| Return On Equity | 0.25 | |||
| Return On Asset | 0.0556 | |||
| Profit Margin | 0.09 % | |||
| Operating Margin | 0.04 % | |||
| Current Valuation | 4.45 M | |||
| Shares Outstanding | 1.72 M | |||
| Price To Earning | 3.33 X | |||
| Price To Sales | 0.40 X | |||
| Revenue | 21.6 M | |||
| EBITDA | 991.1 K | |||
| Cash And Equivalents | 104.55 K | |||
| Cash Per Share | 0.06 X | |||
| Total Debt | 466.84 K | |||
| Debt To Equity | 0.31 % | |||
| Book Value Per Share | 4.95 X | |||
| Cash Flow From Operations | (465.77 K) | |||
| Earnings Per Share | 1.08 X | |||
About Pd Rx Performance
Evaluating Pd Rx's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Pd Rx has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Pd Rx has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
PD-Rx Pharmaceuticals, Inc. engages in the repackaging and distribution of prepackaged pharmaceutical products for the healthcare industry in the United States. PD-Rx Pharmaceuticals, Inc. was incorporated in 1986 and is headquartered in Oklahoma City, Oklahoma. Pd-Rx Pharmaceutical operates under Medical Distribution classification in the United States and is traded on OTC Exchange.Things to note about Pd Rx Pharmaceutical performance evaluation
Checking the ongoing alerts about Pd Rx for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Pd Rx Pharmaceutical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Pd Rx Pharmaceutical currently holds about 104.55 K in cash with (465.77 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.06. |
- Analyzing Pd Rx's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Pd Rx's stock is overvalued or undervalued compared to its peers.
- Examining Pd Rx's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Pd Rx's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Pd Rx's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Pd Rx's pink sheet. These opinions can provide insight into Pd Rx's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for PDRX Pink Sheet Analysis
When running Pd Rx's price analysis, check to measure Pd Rx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pd Rx is operating at the current time. Most of Pd Rx's value examination focuses on studying past and present price action to predict the probability of Pd Rx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pd Rx's price. Additionally, you may evaluate how the addition of Pd Rx to your portfolios can decrease your overall portfolio volatility.